18 results
10-Q
2021 Q2
CADL
Candel Therapeutics Inc
8 Sep 21
Quarterly report
8:37am
) additions or modifications to product labeling, (iii) the recall or discontinuation of our products or (iv) additional record-keeping requirements … , refusal to permit the import or export of the products, product seizure, detention, or recall, operating restrictions, suits under the civil False
S-1
CADL
Candel Therapeutics Inc
25 Jun 21
IPO registration
5:28pm
, for example: (i) changes to our manufacturing arrangements, (ii) additions or modifications to product labeling, (iii) the recall or discontinuation of our … seizure, detention, or recall, operating restrictions, suits under the civil False Claims Act, corporate integrity agreements, consent decrees
DRS/A
CADL
Candel Therapeutics Inc
31 Mar 21
Draft registration statement (amended)
12:00am
) additions or modifications to product labeling, (iii) the recall or discontinuation of our products or (iv) additional record-keeping requirements … seizure, detention, or recall, operating restrictions, suits under the civil False Claims Act, corporate integrity agreements, consent decrees
S-1/A
6vrc0ec0vkn3p dt
16 Jul 21
IPO registration (amended)
6:07am
424B4
0zg44mf6n5s3f avuuw1
28 Jul 21
Prospectus supplement with pricing info
4:02pm
10-K
fe0weh2u
29 Mar 22
Annual report
8:46am
- Prev
- 1
- Next